HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â04¿ù19ÀÏfri
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-04-19 17:18:24
´º½ºÈ¨ > µ¿Á¤
2011³â08¿ù10ÀÏ 00½Ã00ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
ȲÁØÀÏ ±³¼ö, ³»°úÇÐȸ ¿ì¼ö³í¹® ¼±Á¤

ȲÁØÀÏ ±³¼ö

È­¼øÀü³²´ëº´¿ø Á¾¾ç³»°ú ȲÁØÀÏ ±³¼ö°¡ ‘¾Ï ȯÀÚ¿¡¼­ ¿°»êÈ÷µå·Î¸ð¸£Æù ¼­¹æÁ¤ÀÇ È¿°ú¿Í ³»¾à¼º¿¡ ´ëÇÑ ¿¬±¸’¶õ ³í¹®À¸·Î ´ëÇѳ»°úÇÐȸ·ÎºÎÅÍ 2011³â »ó¹Ý±â ¿ì¼ö³í¹®¿¡ ¼±Á¤µÆ´Ù.

Ȳ ±³¼öÀÇ ³í¹®Àº The Korean Journal of Internal Medicine 2011³â 3¿ùÈ£¿¡ °ÔÀçµÇ¾ú´ø ‘Efficacy and Tolerability of OROS Hydromorphone in Strong Opioid-Naive Patients:An Open Label, Prospective Study’ (Vol. 80. No. 3. p317~322, 2011)ÀÌ´Ù.

ÇÑÆí ´ëÇѳ»°úÇÐȸ´Â ¸Å³â ¹Ý±âº°·Î ¿ì¼ö³í¹®À» ¼±Á¤, ¼ö»óÇØ¿À°í ÀÖ´Ù.

 

 

 

 

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
Á¶¹æÈÆ (www.bktimes.net) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
µ¿Á¤¼½¼Ç ¸ñ·ÏÀ¸·Î
½Åµ¿Ãµ ÀÇÇù ±¹Á¦Çù·Â½ÇÇà...
±è¿Á¿¬ Çѱ¹¾á¼¾ »çÀå, ¾Æ ...
Á߾Ӵ뺴¿ø ÀÌ¹Ì°æ ±³¼ö, '...
±è¼º±Ô ±³¼ö, ¼¼°è³»°úÇÐȸ...
ÀÌ´ë¼­¿ï ÀÌÁøÈ­ Æó¼¾ÅÍÀå,...
´ÙÀ½±â»ç : Á߾Ӵ뺴¿ø °­°æÈ£ ±³¼ö, È«Äá °©»ó¼±ÇÐȸ ÃÊû °­¿¬ (2011-08-12 00:00:00)
ÀÌÀü±â»ç : °ûÁ¤¼÷ ÀÇ¿ø, ÅÂdz ÇÇÇØÁö¿ª ³ó°¡ À§·Î (2011-08-09 00:00:00)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Overcoming BRAF and CDK4/6 inhibitor ...  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶